TrialHepatology (Baltimore, Md.)2026

Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferase.

Andrew S Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.